| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |